Chemed (CHE) Competitors $549.20 -4.64 (-0.84%) Closing price 06/11/2025 03:59 PM EasternExtended Trading$548.86 -0.34 (-0.06%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CHE vs. LH, DGX, DVA, CRVL, AMED, MD, AMN, CCRN, OPCH, and BTSGShould you be buying Chemed stock or one of its competitors? The main competitors of Chemed include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Option Care Health (OPCH), and BrightSpring Health Services (BTSG). Chemed vs. Its Competitors Laboratory Co. of America Quest Diagnostics DaVita CorVel Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Option Care Health BrightSpring Health Services Chemed (NYSE:CHE) and Laboratory Co. of America (NYSE:LH) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations. Which has preferable valuation and earnings, CHE or LH? Laboratory Co. of America has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than Laboratory Co. of America, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemed$2.49B3.23$272.51M$20.5326.75Laboratory Co. of America$13.18B1.65$746M$8.6530.05 Does the MarketBeat Community favor CHE or LH? Laboratory Co. of America received 294 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 63.92% of users gave Laboratory Co. of America an outperform vote while only 63.57% of users gave Chemed an outperform vote. CompanyUnderperformOutperformChemedOutperform Votes33563.57% Underperform Votes19236.43% Laboratory Co. of AmericaOutperform Votes62963.92% Underperform Votes35536.08% Does the media favor CHE or LH? In the previous week, Laboratory Co. of America had 3 more articles in the media than Chemed. MarketBeat recorded 11 mentions for Laboratory Co. of America and 8 mentions for Chemed. Laboratory Co. of America's average media sentiment score of 1.10 beat Chemed's score of 1.04 indicating that Laboratory Co. of America is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Laboratory Co. of America 7 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CHE or LH more profitable? Chemed has a net margin of 12.69% compared to Laboratory Co. of America's net margin of 5.73%. Chemed's return on equity of 27.86% beat Laboratory Co. of America's return on equity.Company Net Margins Return on Equity Return on Assets Chemed12.69% 27.86% 19.12% Laboratory Co. of America 5.73%15.29%7.01% Do institutionals & insiders have more ownership in CHE or LH? 95.8% of Chemed shares are held by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are held by institutional investors. 3.3% of Chemed shares are held by insiders. Comparatively, 0.8% of Laboratory Co. of America shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is CHE or LH a better dividend stock? Chemed pays an annual dividend of $2.00 per share and has a dividend yield of 0.4%. Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.1%. Chemed pays out 9.7% of its earnings in the form of a dividend. Laboratory Co. of America pays out 33.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has increased its dividend for 16 consecutive years. Which has more volatility & risk, CHE or LH? Chemed has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Do analysts rate CHE or LH? Chemed currently has a consensus price target of $674.00, indicating a potential upside of 22.72%. Laboratory Co. of America has a consensus price target of $274.00, indicating a potential upside of 5.40%. Given Chemed's stronger consensus rating and higher probable upside, equities analysts plainly believe Chemed is more favorable than Laboratory Co. of America.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Laboratory Co. of America 0 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.86 SummaryLaboratory Co. of America beats Chemed on 12 of the 22 factors compared between the two stocks. Get Chemed News Delivered to You Automatically Sign up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHE vs. The Competition Export to ExcelMetricChemedHome health care services IndustryMedical SectorNYSE ExchangeMarket Cap$8.03B$3.13B$5.57B$19.81BDividend Yield0.36%0.36%5.28%3.84%P/E Ratio27.7523.7227.1235.67Price / Sales3.231.12412.3046.74Price / Cash22.4017.2938.2517.52Price / Book7.473.547.064.84Net Income$272.51M-$57.02M$3.23B$1.02B7 Day Performance-1.89%-2.38%2.86%1.94%1 Month Performance-3.57%-2.23%9.07%3.03%1 Year Performance1.42%26.00%31.45%9.73% Chemed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHEChemed4.6365 of 5 stars$549.20-0.8%$674.00+22.7%+2.0%$8.03B$2.49B27.7514,200Positive NewsShort Interest ↑LHLaboratory Co. of America4.3665 of 5 stars$247.74-0.5%$272.92+10.2%+31.7%$20.74B$13.18B28.0975,500Positive NewsAnalyst ForecastDGXQuest Diagnostics4.8866 of 5 stars$174.31+0.6%$185.73+6.6%+25.6%$19.46B$10.16B22.6749,000Positive NewsDVADaVita3.846 of 5 stars$134.44-1.3%$164.50+22.4%-1.3%$10.15B$12.97B12.5270,000CRVLCorVel0.9119 of 5 stars$111.08-0.2%N/A+37.8%$5.70B$895.59M65.344,230Positive NewsInsider TradeAMEDAmedisys3.2945 of 5 stars$94.49+0.4%$100.75+6.6%+5.5%$3.10B$2.37B37.5020,000Positive NewsMDPediatrix Medical Group1.415 of 5 stars$13.54-4.3%$16.67+23.1%+110.1%$1.16B$1.98B-11.287,850Positive NewsShort Interest ↑AMNAMN Healthcare Services4.3722 of 5 stars$20.28-3.9%$32.08+58.2%-59.0%$776.42M$2.85B-5.274,230Positive NewsCCRNCross Country Healthcare4.0899 of 5 stars$13.15-0.2%$17.93+36.3%-10.7%$431.10M$1.26B-262.952,700Positive NewsOPCHOption Care Health4.0088 of 5 stars$31.86-2.5%$35.50+11.4%+12.2%$5.22B$5.19B26.775,600Positive NewsBTSGBrightSpring Health Services0.7752 of 5 stars$23.93+0.5%$23.56-1.6%+101.9%$4.17B$11.86B-92.0435,000 Related Companies and Tools Related Companies Laboratory Co. of America Alternatives Quest Diagnostics Alternatives DaVita Alternatives CorVel Alternatives Amedisys Alternatives Pediatrix Medical Group Alternatives AMN Healthcare Services Alternatives Cross Country Healthcare Alternatives Option Care Health Alternatives BrightSpring Health Services Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CHE) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.